医疗保健服务提供商Astrana Health近日再次确认了其2026财年的财务目标。公司预计全年总收入将达到38亿至41亿美元区间，展现出稳健的增长态势。
在盈利能力方面，Astrana Health预计调整后的税息折旧及摊销前利润（EBITDA）将介于2.5亿至2.8亿美元之间。这一指标充分反映了公司运营效率的持续优化。
更值得关注的是，公司对自由现金流的预测维持在1.05亿至13.25亿美元的水平。强劲的现金流生成能力将为Astrana Health的未来发展战略提供坚实支撑。
此次重申的业绩指引与公司先前公布的预期完全一致，彰显了管理层对实现这些财务目标的充分信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.